Table 1. Role of key multifaceted regulators in cancer glucose metabolism.
Metabolism procedures | Key molecules | Potential targets | Biological effects | Refs |
---|---|---|---|---|
Glycolysis process | p53 | GLUT1 and GLUT4 | Prevent the glucose uptake | [32] |
HIF-1 | GLUT1 and GLUT3 | Promote the glucose entry into the tumor cells | [48] | |
HIF-1 | HK2 | Enhance the phosphorylation of glucose | [49] | |
HIF-1 | LDHA and MCT4 | Facilitate the conversion of pyruvate to lactate and the removal of lactate from tumor cells | [51] | |
TIGAR | Fructose-2, 6-bisphosphate | Decrease the glycolytic rate | [63] | |
TIGAR | NADPH | Lower the intracellular ROS level | [67] | |
miR-143 | HK2 | Reduce glucose metabolism and inhibit tumor cell proliferation | [79] | |
miR-155 | STAT3 and C/EBPβ | Control the aerobic glycolysis of tumor cells | [81] | |
miR-195-5p | GLUT3 | Suppress the glucose uptake, inhibit tumor cell growth and promote apoptosis of tumor cells | [82] | |
Oxidative phosphorylation process | p53 | SCO2 and GLS2 | Increase the use of TCA cycle and up-regulate the rate of oxidative phosphorylation | [34, 35] |
HIF-1 | PDK1, MXI1 and COX4 | Repress mitochondrial activities and decrease oxygen consumption in hypoxia | [52] | |
miR-141, miR-200a | p38α | Control tumor oxidative stress response and regulate redox potential | [83] |
Abbreviation: GLUT1: Glucose transporter 1; SCO2: Synthesis of cytochrome c oxidase 2; GLS2: Glutaminase 2; TCA cycle: Tricarboxylic acid cycle; HIF-1: Hypoxia-inducible factor 1; HK2: Hexokinase 2; LDHA: Lactate dehydrogenase A; MCT4: Monocarboxylate transporter 4; PDK1: Pyruvate dehydrogenase kinase 1; MXI1: Max interactor 1; COX4: Cytochrome c oxidase subunit 4.